VAN NOSTRAND LAB

Our research is aimed at studying the role of metabolic checkpoints triggered by AMPK and mTOR signaling in cancer and metabolic disease. We combine approaches in mouse genetics, biochemistry, cell biology, imaging, and metabolomics to dissect these biological processes. A deeper understanding of the interrelationship between cancer and metabolic disease will inform on how cells respond to energy stress and metabolic changes to suppress tumorigenesis and aid in establishing effective preventative and therapeutic strategies for cancer patients.

Primary location: Houston United States